瑞慈醫療(01526.HK)擬1.55億元收購多家附屬30%股權
格隆匯7月17日丨瑞慈醫療(01526.HK)發佈公告,於2020年7月17日,賣方上海新東吳優勝與買方上海瑞慈醫療(公司全資附屬公司)訂立股權轉讓協議,內容有關向買方轉讓於各目標公司30%的股權,總代價為人民幣1.55億元。
截至本公告日期,公司透過其附屬公司間接持有各目標公司51%的股權。於該等交易完成後,賣方將不再持有目標公司的任何股權,公司將透過其附屬公司間接持有各目標公司81%的股權。
目標公司指廣州瑞慈、蘇州瑞慈、南京瑞慈、南通瑞慈、無錫瑞慈、揚州瑞慈、徐州瑞慈。
目標公司位於長三角地區或粵港澳大灣區,即集團擴展其體檢業務戰略的主要地區。於該等交易完成後,公司將增持於目標公司的間接股權比例,從而分佔更多目標公司未來穩定業務發展所帶來的經濟利益。同時,公司對目標公司的控制力將於該等交易完成後得到提升,這有助於提高集團體檢業務的運營效率,有助於未來進一步增強規模效應並提升公司的盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.